News

• IRONMAN: An International Registry To Improve Outcomes in Men wit...

  Press Releases by UroToday April 18, 2018

  

  PCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative. ...

  Learn More

• PCCTC-Developed Apalutamide Gains FDA Approval

  Press Releases by admin March 9, 2018

  

  On February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation AR antagonist apalutamide (Erl...

  Learn More

• PCCTC Muscadine (MPX) Study Finds Activity in Select Genotypes

  Press Releases by admin December 19, 2017

  

  A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) gene as a biomarker shows promis...

  Learn More

• The PCCTC Salutes Its Very Own Angie Avery

  Press Releases by admin November 7, 2017

  

  Celebrating Veterans Week 2017, we salute Angie Avery, PCCTC Project Coordinator. ...

  Learn More

• Timeline of PCCTC Clinical Contributions

  Press Releases by admin November 6, 2017

  

  The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) presents the evolution of the...

  Learn More

• Early Development Led by the PCCTC, FDA Approval Now Sought for A...

  Media Relations by Jason Harris - OncLive October 12, 2017

  

  A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for the treatment of non-metastatic...

  Learn More